Lisa Vandermeer

Preference weights for chemotherapy side effects from the perspective of women with breast cancer

Iryna Kuchuk, Nathaniel Bouganim, K. Beusterien et al. · Breast Cancer Research and Treatment · 2013 · 99 citations

Medicine, Oncology, Pharmacotherapy +15

Use of Conjoint Analysis to Assess Breast Cancer Patient Preferences for Chemotherapy Side Effects

Kathleen Beusterien, Jessica Grinspan, Iryna Kuchuk et al. · The Oncologist · 2014 · 84 citations · Full text

Medicine, Oncology, Pharmacology +15

A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer

Mark Clemons, Michael Ong, Carol Stober et al. · European Journal of Cancer · 2020 · 69 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Prospective Validation of Risk Prediction Indexes for Acute and Delayed Chemotherapy-Induced Nausea and Vomiting

Nathaniel Bouganim, George Dranitsaris, S. Hopkins et al. · Current Oncology · 2012 · 53 citations · Full text

Pharmacy, Oncology, Cancer Symptom Management +16

Risk Model–Guided Antiemetic Prophylaxis vs Physician’s Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer

Mark Clemons, Nathaniel Bouganim, Stephanie Smith et al. · JAMA Oncology · 2015 · 51 citations

Pharmacy, Oncology, Pharmacotherapy +16